Challenger is an insurance - life business based in Australia. Challenger shares (CGF) are listed on the Australian Securities Exchange (ASX) and all prices are in Australian dollars. Challenger has a trailing 12-month revenue of around $3 billion. If you're looking to buy shares, check out the steps below.
To buy shares listed in Australia such as Challenger, you'll need to sign up to a broker with access to the ASX. Our table can help you compare share trading platforms and choose. Then follow these steps.
Our top pick for
Best for beginner
Our top pick for
Education & learning
Our top pick for
Australian stocks
| 52-week range | $5.5664 - $7.17 |
|---|---|
| 50-day moving average | $6.8334 |
| 200-day moving average | $6.4946 |
| Target price | $7.61 |
| PE ratio | 23.5862 |
| Dividend yield | $0.25 (3.8%) |
| Earnings per share (TTM) | $0.29 |
The technical analysis gauge below displays real-time ratings for the timeframes you select. However, this is not a recommendation. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
Historical closes compared with the last close of A$6.75
| 1 week (2024-04-23) | -1.03% |
|---|---|
| 1 month (2024-03-28) | -5.06% |
| 3 months (2024-02-01) | 4.98% |
| 6 months (2023-11-01) | 15.78% |
| 1 year (2023-05-01) | 9.22% |
|---|---|
| 2 years (2022-04-29) | -7.41% |
| 3 years (2021-04-30) | 32.09% |
| 5 years (2019-05-01) | -18.77% |
Valuing Challenger stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Challenger's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Challenger's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 24x. In other words, Challenger shares trade at around 24x recent earnings.
That's relatively low compared to, say, the P/E ratio for the ASX over the 12 months to December 2019 (32.14). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.
Challenger's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $1.3 billion (£0.0 million).
The EBITDA is a measure of a Challenger's overall financial performance and is widely used to measure stock profitability.
| Revenue TTM | $3 billion |
|---|---|
| Operating margin TTM | 41.49% |
| Gross profit TTM | $932 million |
| Return on assets TTM | 2.56% |
| Return on equity TTM | 8.01% |
| Profit margin | 10.53% |
| Book value | 5.695 |
| Market capitalisation | $4.7 billion |
TTM: trailing 12 months
Dividend payout ratio: 81.35% of net profits
Recently Challenger has paid out, on average, around 81.35% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 3.8% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), Challenger shareholders could enjoy a 3.8% return on their shares, in the form of dividend payments. In Challenger's case, that would currently equate to about A$0.25 per share.
Challenger's payout ratio would broadly be considered high, and as such this stock could appeal to those looking to generate an income. Bear in mind however that companies should normally also look to re-invest a decent amount of net profits to ensure future growth.
The latest dividend was paid out to all shareholders who bought their shares by 19 February 2024 (the "ex-dividend date").
Challenger's shares were split on a 1:5 basis on 25 November 2004. So if you had owned 5 shares the day before the split, the next day you would own 1 share. This wouldn't directly have changed the overall worth of your Challenger shares – just the quantity. However, indirectly, the new 400% higher share price could have impacted the market appetite for Challenger shares which in turn could have impacted Challenger's share price.
Over the last 12 months, Challenger's shares have ranged in value from as little as $5.5664 up to $7.17. A popular way to gauge a stock's volatility is its "beta".
Beta measures a share's volatility in relation to the market. The market (AU average) beta is 1, while Challenger's is 0.931. This would suggest that Challenger's shares are less volatile than average (for this exchange).
Challenger Limited is a publicly owned investment manager. The company also provides retirement services to its clients. It manages equity mutual funds. The firm invests into the public equity markets across the world. Challenger Limited was founded in 1985 and is based in Australia, Asia and United Kingdom.
AMP Ltd Preferred
AUD103.99
ANZ Group Holdings Ltd. Pfd.
AUD101.63
ANZ Group Holdings Ltd. Pfd.
AUD103.53
Macquarie Group Ltd Pref C
AUD103.59
Macquarie Group Ltd Pref
AUD106.26
Macquarie Group Preferred
AUD103.14
Macquarie Group Limited
AUD106.35
Suncorp Group Ltd Pref
AUD100.67
Westpac Banking Corp Pref
AUD103.80
Everything we know about the Sun Silver IPO, plus information on how to buy in.
Everything we know about the Tasmea Limited IPO, plus information on how to buy in.
Steps to owning and managing Far Northern Resources shares.
Commodity ETFs can be used to hedge against inflation. Here's what they do, why they should be on your watchlist and how they can help your portfolio.
Looking for the best performing stocks in Australia? We update this list weekly.
Steps to owning and managing Gol Linhas Aéreas Inteligentes SA shares from Australia.
Trade ASX stocks and ETFs with a $2 brokerage fee and a low minimum investment of just $10.
These ETFs have the lowest fees on the market, but does that make them the best?
You've heard of CommSec but how does it stack up to the likes of IG, CMC Invest and other players in the market?
Westpac Share Trading allows you to take control of your investments. Find out if its right for you.